{"schemaVersion":1,"profileUrl":"https://nowen.ai/agents/oig-hhs-gov","markdownUrl":"https://nowen.ai/agents/oig-hhs-gov.md","jsonUrl":"https://nowen.ai/agents/oig-hhs-gov.json","name":"U.S. Department of Health and Human Services Office of Inspector General","nickname":"HHS-OIG","website":"https://oig.hhs.gov","location":"Washington, DC, United States","address":{"city":"Washington","state":"DC","country":"United States"},"status":{"verified":false,"text":"Unclaimed: compiled by Nowen from public sources, not reviewed by the company"},"updatedAt":"2026-10-07T09:37:24.141Z","summary":"HHS-OIG protects the integrity of HHS programs by auditing, investigating, and evaluating for fraud, waste, and abuse.","description":"HHS Office of Inspector General (HHS-OIG) conducts independent audits, evaluations, and investigations of U.S. Department of Health and Human Services programs, operations, and beneficiaries to identify waste, fraud, and abuse and to promote economy, efficiency, and effectiveness. It comprises the Immediate Office and five principal components: Office of Audit Services, Office of Evaluation and Inspections, Office of Investigations, Office of Management and Policy, and Office of Counsel to the Inspector General. HHS-OIG provides public resources such as a Work Plan and Semiannual Report to Congress, offers advisory opinions and compliance guidance, and operates a Hotline to receive tips about fraud, waste, and abuse. Its mission is to protect the integrity of HHS programs and ensure accountability in the use of federal funds, safeguarding beneficiaries and taxpayers. The Office of Investigations emphasizes a national scope and uses state-of-the-art tools to pursue criminal, civil, and administrative cases, aiming to be the world's premier health care law enforcement agency.","mission":"To protect the integrity of Health and Human Services programs by detecting and deterring fraud, waste, and abuse through audits, investigations, evaluations, and guidance.","aiReaderFamilies":["Anthropic","Perplexity"],"products":[{"name":"RAT-STATS","type":"Product","url":"https://oig.hhs.gov/compliance/rat-stats/","summary":"RAT-STATS enables effective claims audits through random sampling and improper payment estimation.","description":"RAT-STATS is a free statistical software package developed by the Office of Inspector General to aid in audits of health care programs. It helps users select random samples for claims reviews and to estimate improper payments from sampled data. The software is provided without formal technical support.","pricing":{"text":"Pricing not published"},"features":[{"name":"Free Software","value":"Access Free Software","valueDescription":"Users can download RAT-STATS without any cost, ensuring broader access for needs related to health care audits."},{"name":"Random Sampling","value":"Select Random Samples","valueDescription":"Enhances the integrity of claims reviews by employing random sampling methods, crucial for effective audit practices."},{"name":"Improper Payments Estimation","value":"Estimate Improper Payments","valueDescription":"Facilitates accurate estimation of improper payments, helping organizations identify areas of concern in financial audits."},{"name":"User-Friendly Design","value":"Utilize User-Friendly Interface","valueDescription":"Optimized for accessibility, RAT-STATS enables users to navigate and utilize its features without extensive statistical training."},{"name":"No Official Technical Support","value":"Understand Limited Support","valueDescription":"Users should note that while RAT-STATS is user-friendly, they must handle technical inquiries independently."}]},{"name":"Advisory Opinions","type":"Service","url":"https://oig.hhs.gov/compliance/advisory-opinions/","summary":"Provides legal clarity on compliance with fraud and abuse laws for business arrangements.","description":"HHS-OIG issues advisory opinions about the application of fraud and abuse enforcement authorities to the requesting party’s existing or proposed business arrangements.","pricing":{"text":"Pricing not published"},"features":[{"name":"Advisory Opinions on Enforcement Authorities","value":"Clarifies Legal Application","valueDescription":"Provides essential guidance on the application of federal anti-kickback statutes and related laws to various business scenarios."},{"name":"Advisory Opinion Process","value":"Facilitates Process Requests","valueDescription":"Streamlines the procedure for businesses to seek legal opinions on compliance with applicable laws."},{"name":"Recent Advisory Opinions","value":"Access Recent Legal Opinions","valueDescription":"Allows stakeholders to stay informed about the latest advisories relevant to business practices."},{"name":"FAQs and Guidance","value":"Enhances Understanding","valueDescription":"Addresses common concerns and clarifies processes surrounding the advisory opinion requests."}]},{"name":"Corporate Integrity Agreements","type":"Service","url":"https://oig.hhs.gov/compliance/corporate-integrity-agreements/","summary":"Enhances compliance and fraud prevention for healthcare entities through structured agreements.","description":"A Corporate Integrity Agreement (CIA) is an agreement between an entity and the Office of Inspector General (OIG) outlining obligations to improve compliance and prevent fraud, often as part of a civil settlement involving allegations of fraud against Federal health care programs.","pricing":{"text":"Pricing not published"},"features":[{"name":"CIA Implementation and Independent Reviews","value":"Enhances Compliance Oversight","valueDescription":"The CIA mandates critical measures for compliance, such as appointing a compliance officer and conducting periodic independent reviews, ensuring adherence to Federal laws."},{"name":"Exclusion Protections During CIA","value":"Protects Program Participation","valueDescription":"During the CIA, OIG’s agreement not to exclude the entity from Federal health care programs allows continued participation and mitigates disruptions in services."},{"name":"Periodic Reporting","value":"Ensures Transparency and Accountability","valueDescription":"Regular reporting on compliance activities to OIG promotes transparency, helping prevent future fraud and ensuring accountability for adherence to the CIA."},{"name":"Breach and Default Provisions","value":"Enables Enforcement of Compliance","valueDescription":"Breach provisions empower OIG to enforce compliance through monetary penalties, ensuring organizations take their obligations seriously."},{"name":"Training Requirements","value":"Cultivates a Culture of Compliance","valueDescription":"Training ensures that staff understand legal obligations and ethical standards, fostering an environment that prioritizes integrity."}]},{"name":"A Roadmap for New Physicians","type":"Service","url":"https://oig.hhs.gov/compliance/physician-education/","summary":"Provides essential guidance for new physicians on compliance with Medicare and Medicaid fraud laws.","description":"Educational materials to assist in teaching physicians about the Federal fraud and abuse laws; includes a booklet, PowerPoint, speaker notes, and narrated content.","pricing":{"text":"Pricing not published"},"features":[{"name":"Roadmap Booklet","value":"Serves as a Self-Study Resource","valueDescription":"The booklet contains comprehensive information on fraud and abuse laws, aiding physicians in their self-education."},{"name":"Accompanying PowerPoint Slides","value":"Enhances Understanding Through Visuals","valueDescription":"The PowerPoint slides provide a structured presentation format to enhance the learning experience for attendees."},{"name":"Speaker Notes","value":"Supports Effective Presentations","valueDescription":"The speaker notes provide additional context and guidance for presenters, ensuring accurate delivery and clarification of concepts."},{"name":"Audio Narration","value":"Facilitates Remote Learning","valueDescription":"The audio narration ensures that remote learners can understand the material clearly, enhancing engagement and retention."}]},{"name":"General Compliance Program Guidance","type":"Service","url":"https://oig.hhs.gov/compliance/compliance-guidance/","summary":"GCPG supports health care providers in navigating compliance with Federal health care laws.","description":"General Compliance Program Guidance (GCPG) provides information about compliance program infrastructure and Federal health care program standards.","pricing":{"text":"Pricing not published"},"features":[{"name":"Industry Segment Guidance","value":"Tailor Compliance Programs To Specific Sectors","valueDescription":"Specific guidance is available for diverse health care sectors, helping organizations navigate compliance effectively."},{"name":"General Guidance on Compliance Programs","value":"Establish Strong Compliance Frameworks","valueDescription":"GCPG provides vital insights on establishing effective compliance programs tailored to meet Federal standards."},{"name":"CPG Archive and Updates","value":"Stay Updated With Compliance Changes","valueDescription":"Users can access a comprehensive archive of compliance program guidance documents, ensuring they remain informed about the latest updates."},{"name":"Advisory Opinions","value":"Access Legal Clarity On Compliance","valueDescription":"Healthcare organizations can request advisory opinions that clarify how specific laws apply to their arrangements."}]},{"name":"OIG Hotline","type":"Service","url":"https://oig.hhs.gov/fraud/report-fraud/","summary":"Provides a confidential way to report healthcare fraud, waste, and abuse.","description":"The Office of Inspector General operates a hotline to receive tips about fraud, waste, and abuse in Federal health care programs via online submission or phone.","pricing":{"text":"Pricing not published"},"features":[{"name":"Online Reporting","value":"Report Online","valueDescription":"Easily submit your complaint through the online form for immediate processing."},{"name":"Phone Reporting","value":"Report By Phone","valueDescription":"Speak directly to a representative for more personal assistance."},{"name":"Anonymous Reporting Option","value":"Report Anonymously","valueDescription":"Allows individuals to submit tips without revealing their identity."},{"name":"Additional Reporting Channels","value":"Multiple Reporting Channels","valueDescription":"Provides flexibility in how reports can be submitted."}]}],"audiences":[],"segments":[{"name":"Regulatory advisory and legal opinion","description":"Formal opinions and written guidance that interpret the application of federal health care fraud and abuse laws to specific business arrangements.","size":0.5,"cagr":9,"color":1,"productNames":["Advisory Opinions"],"methodology":"Estimated U.S. market size derived by applying the observed share of ‘‘legal representation’’ within broader regulatory‑affairs outsourcing reports (~10–11%) to U.S. regulatory‑affairs market totals. Sources show U.S. regulatory affairs ≈ USD 4.55B (2023) and multiple outsourcing/RA market reports report legal representation ≈ USD 1.0B (2025) and overall CAGRs ~8.5–9.3%. Given these inputs and the niche focus on federal health‑care fraud/abuse legal opinions (a high‑specialty legal subsegment), the estimated market is ~USD 0.5B with growth potential near the legal/RA segment CAGR (~9%).","citations":[{"url":"https://www.novaoneadvisor.com/report/us-regulatory-affairs-market","text":"The U.S. regulatory affairs market size was exhibited at USD 4.55 billion in 2023"},{"url":"https://www.prophecymarketinsights.com/market_insight/Regulatory-Affairs-Outsourcing-Market-1114","text":"In 2024, the market valuation was USD 7.1 Billion. The market is growing at a CAGR 8.5%."},{"url":"https://www.marketresearchfuture.com/reports/healthcare-regulatory-affairs-outsourcing-market-7804","text":"The Healthcare Regulatory Affairs Outsourcing Market reached USD 9.16 Billion in 2025"},{"url":"https://www.marketresearchfuture.com/reports/healthcare-regulatory-affairs-outsourcing-market-7804","text":"Legal representation services generated USD 1.00 billion in 2025"},{"url":"https://www.grandviewresearch.com/industry-analysis/north-america-biotechnology-pharmaceutical-services-outsourcing-market-report","text":"The North America biotechnology and pharmaceutical services outsourcing market size was estimated at USD 12.01 billion in 2023"}]},{"name":"Regulatory compliance management","description":"Capabilities that monitor regulatory change, centralize compliance tasks, manage regulatory change processes, and surface expert-backed, auditable guidance for compliance teams.","size":30,"cagr":13,"color":2,"productNames":["Corporate Integrity Agreements","General Compliance Program Guidance"],"methodology":"Estimation synthesizes overlapping market figures from RegTech, GRC, and quality & compliance segments in the provided results. Grand View (RegTech) reports ~USD 24.3B (2025) with high growth; IMARC (GRC) reports USD 54.7B (2025) with ~10.6% CAGR; Coherent reports quality & compliance ~USD 33.06B (2026) with 9.8% CAGR; Precedence reports healthcare compliance software at USD 3.8–4.31B with ~13.2% CAGR. Regulatory compliance management is a subset spanning these categories; a conservative mid-point market size of ~USD 30B and growth potential ~13% CAGR reflects this aggregation and the acceleration from RegTech-specific forecasts.","citations":[{"url":"https://www.grandviewresearch.com/industry-analysis/regulatory-technology-market","text":"The global RegTech market size was valued at USD 24.3 billion in 2025; CAGR (2026-2033): 21.1%."},{"url":"https://www.imarcgroup.com/governance-risk-compliance-platform-market","text":"The global governance, risk and compliance platform market size reached USD 54.7 Billion in 2025; CAGR 2026-2034: 10.62%."},{"url":"https://www.coherentmarketinsights.com/market-insight/quality-and-compliance-management-solution-market-4762","text":"The global quality and compliance management solution market size is estimated to reach USD 33,060 Mn in 2026; CAGR 2026–2033: 9.8%."},{"url":"https://www.precedenceresearch.com/healthcare-compliance-software-market","text":"Healthcare compliance software market size: USD 3.80 billion in 2025, USD 4.31 billion in 2026; CAGR 2026-2035: 13.24%."}]},{"name":"Fraud reporting and investigations","description":"Channels and processes to receive, triage, and investigate allegations of fraud, waste, and abuse affecting federal health care programs.","size":0.8,"cagr":9,"color":3,"productNames":["OIG Hotline"],"methodology":"Estimation based on global fraud detection & prevention market figures from industry reports (KBV, MarketsandMarkets, LinkedIn post) scaled to the narrow subsegment (reporting, triage, investigation) for federal healthcare programs. Global FDP market mid-range ~USD 25–36B (sources). Assume healthcare vertical represents ~10–15% of global FDP ($~2.5–5.4B). Federal health programs (Medicare/Medicaid) comprise a minority of healthcare vertical FDP spend; applying a conservative 15–25% share yields ~$0.4–1.35B for government healthcare fraud solutions. The reporting/triage/investigations channels/processes are a material portion of program-integrity budgets; selecting a central value yields an estimated market size of ~USD 0.8B. Growth potential is lower than commercial FDP CAGR (reported ~17–18%); federal procurement and regulatory cycles imply steadier growth — estimated CAGR ~9% annually.","citations":[{"url":"https://www.kbvresearch.com/fraud-detection-and-prevention-market/","text":"2023 USD 24.84 Billion 2031 USD 103.89 Billion CAGR 18.2%"},{"url":"https://www.marketsandmarkets.com/Market-Reports/geography/fraud-detection-prevention-market/Anz","text":"Market Size Base Year (Billions) ~USD 35.72 (2026) Revenue Forecast (Billions) ~USD 80.01 (2031)"},{"url":"https://www.linkedin.com/posts/srking_partnerpreneur-humanplusmachine-innovation-activity-7401941193942781955-CRDz","text":"expected to grow at a CAGR of 21.2% from 2025 to 2032, resulting in a market size that reaches USD 246.16 billion by 2032."}]},{"name":"Audit sampling and improper payment estimation","description":"Statistical sampling and estimation methods used in claims audits to select samples and estimate improper payments.","size":87.1,"cagr":7.5,"color":4,"productNames":["RAT-STATS"],"methodology":"Estimated addressable annual value equals the sum of documented improper payments reported by CMS across major programs (Medicare FFS, Part C, Part D, Medicaid, CHIP, APTC) (~$87.1B). USDA APEC II findings show similar improper-payment measurement work in school meal programs (percent-of-reimbursement estimates), supporting that statistical sampling/estimation is applied across government programs. Growth potential (CAGR ~7.5%) is an internal estimate reflecting continued regulatory audit activity, persistent multi‑billion-dollar improper payments, and rising adoption of analytics/AI for continuous monitoring and extrapolation in audits.","citations":[{"url":"https://www.cms.gov/newsroom/fact-sheets/fiscal-year-2024-improper-payments-fact-sheet","text":"Medicare FFS estimated improper payment rate was 7.66%, or $31.70 billion; Medicare Part C was 5.61%, or $19.07 billion."},{"url":"https://fns-prod.azureedge.us/sites/default/files/ops/APEC-II-NationalModelingReport-Summary.pdf","text":"CEP certification error were 1.71 percent of total reimbursements (NSLP) and 1.87 percent (SBP)."}]},{"name":"Provider education and compliance","description":"Access to educational materials, guidance, and regulatory updates that help clinicians and organizations comply with federal program rules and implement best practices.","size":3.2,"cagr":11.5,"color":5,"productNames":["A Roadmap for New Physicians"],"methodology":"Estimated as the healthcare-focused portion of the broader compliance-training market. Zion Market Research reports a healthcare data compliance market of ~USD 3.2B (2023) with ~11.5% CAGR; broader compliance-training reports show larger global market estimates (USD ~4.9–5.2B) and higher CAGRs (≈7.5–12.5%), so the 3.2B / ~11.5% estimate is conservative and aligned to provider-facing healthcare compliance.","citations":[{"url":"https://www.zionmarketresearch.com/report/healthcare-data-compliance-market","text":"the global healthcare data compliance market size was worth around USD 3.2 billion in 2023"},{"url":"https://www.zionmarketresearch.com/report/healthcare-data-compliance-market","text":"is predicted to grow to around USD 8.5 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 11.5%"},{"url":"https://www.verifiedmarketreports.com/product/compliance-training-market/","text":"Market Size (2025) 4.89 billion USD; CAGR (2026-2034) 7.5%"},{"url":"https://www.linkedin.com/pulse/compliance-training-market-current-landscape-z5oaf","text":"projected to grow from USD 5.2 billion in 2024 to 13.34 Billion USD by 2033, registering a CAGR of 12.5%"}]}],"faq":[],"comparisons":[],"sources":[{"url":"https://oig.hhs.gov","text":"U.S. Department of Health and Human Services Office of Inspector General"},{"url":"https://oig.hhs.gov/compliance/rat-stats/","text":"RAT-STATS"},{"url":"https://oig.hhs.gov/compliance/advisory-opinions/","text":"Advisory Opinions"},{"url":"https://oig.hhs.gov/compliance/corporate-integrity-agreements/","text":"Corporate Integrity Agreements"},{"url":"https://oig.hhs.gov/compliance/physician-education/","text":"A Roadmap for New Physicians"},{"url":"https://oig.hhs.gov/compliance/compliance-guidance/","text":"General Compliance Program Guidance"},{"url":"https://oig.hhs.gov/fraud/report-fraud/","text":"OIG Hotline"},{"url":"https://www.novaoneadvisor.com/report/us-regulatory-affairs-market","text":"The U.S. regulatory affairs market size was exhibited at USD 4.55 billion in 2023"},{"url":"https://www.prophecymarketinsights.com/market_insight/Regulatory-Affairs-Outsourcing-Market-1114","text":"In 2024, the market valuation was USD 7.1 Billion. The market is growing at a CAGR 8.5%."},{"url":"https://www.marketresearchfuture.com/reports/healthcare-regulatory-affairs-outsourcing-market-7804","text":"The Healthcare Regulatory Affairs Outsourcing Market reached USD 9.16 Billion in 2025"},{"url":"https://www.grandviewresearch.com/industry-analysis/north-america-biotechnology-pharmaceutical-services-outsourcing-market-report","text":"The North America biotechnology and pharmaceutical services outsourcing market size was estimated at USD 12.01 billion in 2023"},{"url":"https://www.grandviewresearch.com/industry-analysis/regulatory-technology-market","text":"The global RegTech market size was valued at USD 24.3 billion in 2025; CAGR (2026-2033): 21.1%."},{"url":"https://www.imarcgroup.com/governance-risk-compliance-platform-market","text":"The global governance, risk and compliance platform market size reached USD 54.7 Billion in 2025; CAGR 2026-2034: 10.62%."},{"url":"https://www.coherentmarketinsights.com/market-insight/quality-and-compliance-management-solution-market-4762","text":"The global quality and compliance management solution market size is estimated to reach USD 33,060 Mn in 2026; CAGR 2026–2033: 9.8%."},{"url":"https://www.precedenceresearch.com/healthcare-compliance-software-market","text":"Healthcare compliance software market size: USD 3.80 billion in 2025, USD 4.31 billion in 2026; CAGR 2026-2035: 13.24%."},{"url":"https://www.kbvresearch.com/fraud-detection-and-prevention-market/","text":"2023 USD 24.84 Billion 2031 USD 103.89 Billion CAGR 18.2%"},{"url":"https://www.marketsandmarkets.com/Market-Reports/geography/fraud-detection-prevention-market/Anz","text":"Market Size Base Year (Billions) ~USD 35.72 (2026) Revenue Forecast (Billions) ~USD 80.01 (2031)"},{"url":"https://www.linkedin.com/posts/srking_partnerpreneur-humanplusmachine-innovation-activity-7401941193942781955-CRDz","text":"expected to grow at a CAGR of 21.2% from 2025 to 2032, resulting in a market size that reaches USD 246.16 billion by 2032."},{"url":"https://www.cms.gov/newsroom/fact-sheets/fiscal-year-2024-improper-payments-fact-sheet","text":"Medicare FFS estimated improper payment rate was 7.66%, or $31.70 billion; Medicare Part C was 5.61%, or $19.07 billion."},{"url":"https://fns-prod.azureedge.us/sites/default/files/ops/APEC-II-NationalModelingReport-Summary.pdf","text":"CEP certification error were 1.71 percent of total reimbursements (NSLP) and 1.87 percent (SBP)."},{"url":"https://www.zionmarketresearch.com/report/healthcare-data-compliance-market","text":"the global healthcare data compliance market size was worth around USD 3.2 billion in 2023"},{"url":"https://www.verifiedmarketreports.com/product/compliance-training-market/","text":"Market Size (2025) 4.89 billion USD; CAGR (2026-2034) 7.5%"},{"url":"https://www.linkedin.com/pulse/compliance-training-market-current-landscape-z5oaf","text":"projected to grow from USD 5.2 billion in 2024 to 13.34 Billion USD by 2033, registering a CAGR of 12.5%"}]}